Joshua Silverman

Affiliations

  • Executive Chairman at Ayro Inc. (AYRO), 2024-12-03
  • at Femasys Inc (FEMY), 2024-07-15
  • Director at Synaptogenix Inc. (SNPX), 2024-04-10
  • Director at Petros Pharmaceuticals Inc. (PTPI), 2023-12-26
  • Interim Ceo, Interim President at Pharmacyte Biotech Inc. (PMCB), 2023-11-22
  • Director at Mymd Pharmaceuticals Inc. (MYMD), 2023-06-09
  • Director at Neurotrope Inc. (NTRP), 2020-12-04
  • Director at Protagenic Therapeutics Inc.w (PTIX), 2020-02-27
  • Director at Tapimmune Inc. (TPIV), 2018-10-17
  • Director at National Holdings Corp (NHLD), 2016-09-13
  • Other at Mgt Capital Investments Inc (MGT), 2016-05-07
  • Director at Alanco Technologies Inc (ALAN), 2016-03-11
  • Large Shareholder at 24Holdings Inc (TWFH), 2013-05-14
  • Large Shareholder at Vringo Inc (VRNG), 2011-12-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MYMD $7.55 5,000 Director 88,775 2021-11-26 Filing
MYMD $7.09 3,266 Director 83,775 2021-11-24 Filing
MYMD $6.30 6,734 Director 80,509 2021-11-24 Filing
SNPX $8.30 10,000 Director 15,000 2021-06-14 Filing
NTRP $1.09 50,000 Director 100,000 2020-10-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AYRO $0.82 12,740 Director 395,493 2023-08-01 Filing
AYRO $0.49 11,927 Director 408,233 2023-05-03 Filing
AYRO $0.71 7,171 Director 222,827 2023-01-30 Filing
SNPX $1.17 19,012 Director 38,238 2022-12-16 Filing
AYRO $0.59 7,171 Director 229,998 2022-11-01 Filing